Welcome to The Symptoms Of Multiple Sclerosis
Autoimmune Disease Multiple Sclerosis Article
This is a selection among article about Autoimmune Disease Multiple Sclerosis. For a permanent link to this article, or to bookmark it for further reading, click here.
Finding Hope Among Shattered Dreams
from: By: News Canada(NC)-At the promising young age of 28, Melanie Jasmin was a talented and energetic woman with a hopeful future. The Montreal lawyer happily spent her days concentrating on her career, nurturing her personal relationships and practicing dance with an amateur dance troupe. Life was ideal.
Then, on a normal workday in February 1998, Melanie began to feel dizzy. Assuming she was overtired, she figured she had to slow down. Within 48 hours, she began to experience double vision and after a couple of days, she went to a doctor.
Within a week she was diagnosed with Multiple Sclerosis (MS), a debilitating disease of the central nervous system. Melanie was shattered.
"You can't imagine how this diagnosis changed everything," says Melanie. "I thought my life had no meaning anymore."
After carefully considering her options, Melanie began to pick up the pieces. She was determined to face the diagnosis with strength, intelligence and a positive attitude. She wanted to find a treatment that was both effective and that would ensure her quality-of-life. Melanie chose Avonex® (interferon beta-1a), which is taken only once-a-week where other MS treatments require injections daily or every other day.
"Because Avonex® is injected into the muscle, I don't get unsightly injection site reactions, which is important for
my self confidence and when I'm performing," said Melanie. "And with a once-a-week treatment, I never forget to take it and I only feel tired for about a day after the injection. That means I have the energy to keep up with my work, my family and my dancing."
Melanie took a few months off from dancing after her diagnosis but she has returned to her normal life and considers herself to be 98 per cent as well as she was before the attack. She believes that taking care of herself, staying optimistic and being diligent about her treatments are the best way to face the disease.
"The one thing MS has taught me is to appreciate everything I have - family, friends, work. Life is a gift and I'm going to take advantage of every opportunity," she says.
About The Author News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web. News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. |
This article was posted on August 4, 2002
Autoimmune Disease Multiple Sclerosis News
HEALTH MATTERS: Living with multiple sclerosis
Multiple sclerosis can be a frustrating disease, as it is largely unpredictable with disabling symptoms that typically come and go.
Read more...Research and Markets: Autoimmune Disease Therapeutics - Global Strategic Business Report
Research and Markets has announced the addition of the "Autoimmune Disease Therapeutics - Global Strategic Bus
Read more...Press Release
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns Disease (Biologics), and Others.
Read more...Multiple sclerosis drug Gilenya under investigation by FDA and EMA
The US Food and Drugs Administration (FDA) and European Medicines Agency (EMA) are looking at the pros and cons of using Gilenya (fingolimod) in treating the neurological autoimmune disease Multiple Sclerosis (MS).
Read more...Rebif® For Early Symptoms Of Multiple Sclerosis, UK
Rebif® (interferon beta-1a), a disease-modifying medication used to treat relapsing forms of multiple Sclerosis (MS), is now available in the UK to treat individuals with clinically isolated syndrome (CIS), a potential early indicator of MS, announced Merck Serono, a division of Merck KGaA, Darmstadt, Germany. The announcement comes after the recent positive opinion adopted by the Committee of ...
Read more...
Small business development & consulting firm.